Once-Daily Fixed-Dose HIV Combo Drug from Mylan NV Receives Tentative Approval from FDA
February 20th 2018Mylan NV's new drug application for its combo regimen of dolutegravir, emtricitabine, and tenofovir alafenamide, received tentative approval from the US Food and Drug Administration under the President's Emergency Plan for AIDS Relief (PEPFAR).